Thyroid Cancer Update

Endocrinology and Metabolism Clinics of North America · Published 2025-07-25 · DOI 10.1016/s0889-8529(25)00063-5

Authors being retrieved — see the publisher record. https://doi.org/10.1016/s0889-8529(25)00063-5

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Clinical Guidance on the Safe Use of Sodium-Glucose Cotransporter Inhibitors in Adults with Type 1 Diabetes · Endocrinology and Metabolism Clinics of North America · 2026 · Same journal
• Emerging Evidence for Cardiorenal Protection with Sodium–Glucose Cotransporter Inhibitors, Glucagon-like peptide-1 Receptor Agonists, and Mineralocorticoid Receptor Blockers in People with Type 1 Diabetes · Endocrinology and Metabolism Clinics of North America · 2026 · Same journal
• Bone Health in Acromegaly · Endocrinology and Metabolism Clinics of North America · 2025 · Same journal
• Thyrotoxicosis · Endocrinology and Metabolism Clinics of North America · 2026 · Same journal
• Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 1 Diabetes · Endocrinology and Metabolism Clinics of North America · 2026 · Same journal
• Adjunctive Therapies in Type 1 Diabetes · Endocrinology and Metabolism Clinics of North America · 2026 · Same journal
• Diagnosis of Cushing’s Disease · Endocrinology and Metabolism Clinics of North America · 2025 · Same journal
• Approach to the Hypoglycemic Patient · Endocrinology and Metabolism Clinics of North America · 2026 · Same journal
• Clinical Guidance on the Safe Use of Glucagon-like Peptide-1 Receptor Agonists in Adults with Type 1 Diabetes · Endocrinology and Metabolism Clinics of North America · 2026 · Same journal
• Adrenal Disorders in Pregnancy · Endocrinology and Metabolism Clinics of North America · 2026 · Same journal